GMEB1 expression based on
|
Comparison | Statistical significance |
Normal-vs-Primary | 1.676180E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.628400E-02 |
Normal-vs-Stage2 |
3.623100E-04 |
Normal-vs-Stage3 |
3.041500E-04 |
Normal-vs-Stage4 |
1.597620E-03 |
Stage1-vs-Stage2 |
4.333700E-02 |
Stage1-vs-Stage3 |
4.282500E-02 |
Stage1-vs-Stage4 |
1.308050E-01 |
Stage2-vs-Stage3 |
6.035000E-01 |
Stage2-vs-Stage4 |
4.432200E-01 |
Stage3-vs-Stage4 |
7.642400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.540000E-03 |
Normal-vs-AfricanAmerican |
8.072400E-01 |
Normal-vs-Asian |
6.388400E-02 |
Caucasian-vs-AfricanAmerican |
7.728100E-02 |
Caucasian-vs-Asian |
5.571800E-01 |
AfricanAmerican-vs-Asian |
2.461600E-01 |
|
|
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.99141999999153E-05 |
Normal-vs-Female |
1.062100E-02 |
Male-vs-Female |
9.804200E-03 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.177370E-01 |
Normal-vs-Age(41-60Yrs) |
2.638900E-04 |
Normal-vs-Age(61-80Yrs) |
9.6438000000032E-05 |
Normal-vs-Age(81-100Yrs) |
5.213800E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.597800E-03 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.698900E-03 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.041000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.046200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.224200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.801800E-01 |
|
|
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Classical-VS-Tall |
1.795850E-02 |
Classical-VS-Follicular |
7.53799999975158E-07 |
Classical-VS-Other |
1.782550E-01 |
Classical-VS-Normal |
6.790400E-02 |
Tall-VS-Follicular |
4.620600E-01 |
Tall-VS-Other |
8.886800E-01 |
Tall-VS-Normal |
8.169800E-04 |
Follicular-VS-Other |
7.892200E-01 |
Follicular-VS-Normal |
7.59049999965455E-07 |
Other-VS-Normal |
4.008500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.011060E-04 |
Normal-vs-N1 |
4.721100E-03 |
N0-vs-N1 |
5.792200E-01 |
|
|